Hindware Home Innovation Ltd

The transcript provided does not explicitly mention the current or expected order book or pending orders for Hindware Home Innovation Limited. Key points related to business outlook and demand are: - Bathware division saw resilience with revenue of about INR326 crore in Q1 FY25 despite challenging market conditions. - Secondary sales have seen positive momentum since late June, with expectations of further momentum into the festive season. - Pipe business reported sales of INR163 crore in Q1 FY25; strong volume growth of 24% YoY with new product launches expected. - Roorkee pipe plant commissioning expected by Q3 FY25, which may boost capacity and order fulfillment. - Market conditions are improving gradually; positive secondary sales point towards potential order growth in H2 FY25. No specific quantification of order book or pending orders is disclosed in the call transcript.

- The Board has approved raising funds through a rights issue of equity shares for an aggregate amount not exceeding INR 205 crore, subject to regulatory approvals. - The primary purpose of the rights issue is to improve liquidity and substantially pay off existing debt. - Besides the INR 200 crore rights issue, no additional equity fundraising is currently confirmed, but the company is evaluating various options and will inform the exchanges once any decisions are approved by the Board. - On the debt front, no explicit new debt raising plans were disclosed; however, the company’s net debt increased by INR 100 crore sequentially due to working capital pressures and ongoing capex. - Capex includes INR 170-180 crore planned for the new Roorkee plant and debottlenecking activities during FY25, which is being financed mainly through existing resources and the rights issue.

- Hindware is undergoing a capex program including setting up a new pipe plant in Roorkee and debottlenecking in the Pipes division. - Total planned investment for FY25 is around INR 170-180 crore, with about 40% already spent (land and civil work mostly done, machinery installation underway). - Normal capex excluding the Roorkee plant is estimated at INR 70-80 crore annually. - The Roorkee plant’s commercial operations are expected to start by Q3 FY25. - Focus on in-sourcing to reduce reliance on imports, especially in Bathware, which is expected to improve margins. - Strategic investments aim to boost volume growth and improve operational efficiencies across businesses. - No additional equity planned beyond the INR 200 crore rights issue for liquidity and debt reduction unless further Board decisions occur.

- Hindware Home Innovation aims for medium to long-term sales growth of 15% to 18% CAGR. - Pipes business volume growth expected at 16% to 18% annually; capacity currently sufficient to meet this growth. - Bathware business anticipates market growth post-H2 FY25 with expected industry growth of 8% to 10%, aiming to outperform industry by 1.25x to 1.5x. - Consumer appliances expected to stabilize with positive revenue growth and margin improvements following restructuring. - Pipe business expects strong volume growth supported by new product launches and expanded offerings. - Overall company targets EBITDA CAGR growth of around 20% over the next 3-4 years. - Market conditions and festival season expected to improve secondary sales and overall demand in H2 FY25.

- Hindware aims for medium to long-term sales growth of 15% to 18% CAGR. - They target over 20% CAGR growth in EBITDA over the next 3-4 years. - Current EBITDA margin at Hindware is around 13.5%; management expects a 2% expansion in the next 2-3 years. - Bathware business has the potential to deliver 17% to 18% EBITDA margins when normalized. - The pipes business forecasts double-digit EBITDA margin growth, expecting improved margins in Q3 and Q4 due to seasonal trends and volume growth. - Management anticipates steady market recovery in H2 FY25 with industry growth around 8%-10%. - Rights issue of INR 200 crore planned to improve liquidity and reduce debt, supporting operational improvements. - Overall, a positive outlook on margin improvement and volume-driven earnings growth, contingent on market recovery and internal cost optimization.